Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
José Bernardo
José Bernardo Carvalho De Andrade, Macapa BR
| Patent application number | Description | Published |
|---|---|---|
| 20120130155 | DEVICE FOR THE TREATMENT OF FEMALE URINARY INCONTINENCE AND VAGINAL FLACCIDITY - A device for the treatment of female urinary incontinence and vaginal flaccidity including a silicon elastomer catheter of 10 cm in length×2.3 mm width and a rigid silicon connector in the shape of an hour glass that connects the extremities of the catheter to surgically treat female urinary incontinence and vaginal flaccidity. | 05-24-2012 |
José Bernardo Iturraspe, Santa Fe AR
| Patent application number | Description | Published |
|---|---|---|
| 20090215882 | LYOPHILIZED SOLID TAXANE COMPOSITION, A PROCESS FOR PREPARING SAID SOLID COMPOSITION, A PHARMACEUTICAL FORMULATION AND A KIT FOR SAID FORMULATION - A lyophilized solid composition of taxane (preferably docetaxel and paclitaxel), is suitable to prepare a pharmaceutical formulation to be administered to mammals, particularly humans, comprising a taxane, a tensoactive, a lyophilizing excipient, and acid; also essentially free from organic solvents. The solid composition is free from polysorbate 80 and polyoxyethylated castor oil; it is sterile; it is soluble in aqueous solutions in the absence of organic solvent and it has an apparent density from 0.05 g/ml to 0.45 g/ml. A procedure of double lyophilization obtains a solid composition of taxane. A pharmaceutical formulation of a taxane comprises a solid composition of lyophilized taxane and a solubilizing composition. A kit comprises the compositions and a syringe. | 08-27-2009 |
| 20090215883 | Pharmaceutical formulation comprising taxane, a solid composition of taxane, a process for preparing said solid composition of taxane, a solubilizing composition of said solid composition of taxane, and a kit for the injectable formulation of taxane - A pharmaceutical formulation of taxane intended to be administered to mammals, preferably humans, comprises two compositions combined prior to being administered, forming a transparent solution free from precipitates, in which the compositions comprise a solid composition of lyophilized taxane, free from tensoactives, oils, polymers, solubility enhancers, preservatives and excipients; and a solubilizing composition of the lyophilized taxane solid composition that comprises at least one tensoactive. This formulation is free from polysorbate 80 and polyoxyethylated castor oil. A procedure is provided for the preparation of the solid composition by means of the lyophilization of taxane in a lyophilizing organic solvent. A kit for the injectable formulation of taxane comprises a prefilled syringe. Also a pharmaceutical taxane solution for perfusion, free from organic solvent, is provided. | 08-27-2009 |
| 20100255104 | PHARMACEUTICAL FORMULATION OF TAXANE - A pharmaceutical formulation of taxane to be administered to mammals, preferably humans, including two compositions which are combined prior to their administration, forming a transparent solution free from precipitates and essentially free from foam, wherein said compositions comprise a solid composition of taxane and a solubilizing composition of said solid taxane composition comprising a tensoactive and an antifoam agent. A kit for such a formulation of injectable taxane includes a prefilled syringe. Also there is a pharmaceutical taxane perfusion solution. | 10-07-2010 |
José Bernardo Iturraspe, Santa Fe AR
| Patent application number | Description | Published |
|---|---|---|
| 20100255104 | PHARMACEUTICAL FORMULATION OF TAXANE - A pharmaceutical formulation of taxane to be administered to mammals, preferably humans, including two compositions which are combined prior to their administration, forming a transparent solution free from precipitates and essentially free from foam, wherein said compositions comprise a solid composition of taxane and a solubilizing composition of said solid taxane composition comprising a tensoactive and an antifoam agent. A kit for such a formulation of injectable taxane includes a prefilled syringe. Also there is a pharmaceutical taxane perfusion solution. | 10-07-2010 |
José Bernardo Parra Soto, Madrid ES
| Patent application number | Description | Published |
|---|---|---|
| 20110126708 | Gas Adsorbents Based on Microporous Coordination Polymers - The invention relates to gas adsorbents based on metal-organic microporous coordination polymers of the metallic bispyrmidinolate-type with a sodalite-type topology, having an adsorbent performance that is typical of crystalline microporous materials. The aforementioned materials also have a large accessible pore volume of between 25 and 45% of the total volume of the material with a monodispersion of pores having diameters of less than 1.3 nm. In addition, the materials have a high capacity for adsorption of small gases, such as carbon monoxide, carbon dioxide, hydrogen, nitrogen, methane, acetylene, etc., which is reversible such that, once said gases have been stored, they can be desorbed. Moreover, owing to the crystalline nature thereof, said materials are suitable for applications associated with the selective adsorption of small molecules such as for the safe storage of combustible gases and for the purification of gases with the elimination of trace impurities using dehydrated metal-organic porous compounds. | 06-02-2011 |